Showing results (351-360 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|November 23, 2019
Targeting DNA methylation for treating triple-negative breast cancerJia Yu, Jacqueline Zayas, Bo Qin, et al.
Pharmacogenomics|December 19, 2019
Germline variants and response to systemic therapy in advanced prostate cancerEric Johnson, Roberto Nussenzveig, Neeraj Agarwal, et al.
Pharmacogenomics|March 13, 2020
Phenylethanolamine N-methyltransferase gene polymorphisms associate with crisis pain in sickle cell disease patientsNilanjana Sadhu, Ellie H Jhun, Andrew Posen, et al.
Pharmacogenomics|January 24, 2019
Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndromeGhada M Ezzat, Ahlam B Ali, Nahed A Mohamed, et al.
Pharmacogenomics|January 11, 2019
Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patientsFrank Eektimmerman, Cornelia F Allaart, Johanna M Hazes, et al.
Pharmacogenomics|January 21, 2020
The emergent phenomenon of aspirin resistance: insights from genetic association studiesMárcia Ferreira, Margarida Freitas-Silva, Joana Assis, et al.
Pharmacogenomics|February 8, 2019
Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approachYong Han, Hong Zhou, Jie Cai, et al.
Pharmacogenomics|December 7, 2018
CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirementsKarla I Claudio-Campos, Pablo González-Santiago, Jessica Y Renta, et al.
Pharmacogenomics|December 7, 2018
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancerEleonora Rofi, Caterina Vivaldi, Marzia Del Re, et al.
Pharmacogenomics|December 7, 2018
Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trialsChad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, et al.
Pageof 274